Comparison of the dose-response pharmacodynamic profiles of detemir and glargine in severely obese patients with type 2 diabetes: A single-blind, randomised cross-over trial

por Bilz, Stefan, Flückiger, Miriam, Meienberg, Fabian, Falconnier, Claudine, Keller, Ulrich, Puder, Jardena J.
Publicado 2018